Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma

BACKGROUND: The molecular profiling of glioblastoma (GBM) based on transcriptomic analysis could provide precise treatment and prognosis. However, current subtyping (classic, mesenchymal, neural, proneural) is time-consuming and cost-intensive hindering its clinical application. A simple and efficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Minjie, Zhang, Jinsen, Li, Weifeng, He, Shan, Zhang, Jingwen, Tennant, Daniel, Hua, Wei, Mao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474912/
https://www.ncbi.nlm.nih.gov/pubmed/34565408
http://dx.doi.org/10.1186/s12967-021-03083-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474912/
https://www.ncbi.nlm.nih.gov/pubmed/34565408
http://dx.doi.org/10.1186/s12967-021-03083-y

Ejemplares similares